10/21/2026
The FORTIFI-HN01 clinical trial is currently enrolling eligible adults with head and neck squamous cell carcinoma ( ) that has returned or spread to other parts of the body.
Learn more about the trial, eligibility criteria, and participating U.S. locations at fortificlinicaltrial.com